ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Global Synthetic Biology Tools Market 2018|Types, Applications ,Opportunities into Regions,Trend and Growth … – Expert Consulting

Global Synthetic Biology Tools Market 2018|Types, Applications ,Opportunities into Regions,Trend and Growth …Expert ConsultingSynthetic Biology Tools market shows an Active growth during the forecast period 2018-2025. Synthetic Biology Tools market r… Continue reading

2018-05-25 Michael Zand NEWS

Global Synthetic Biology Tools Market 2018|Types, Applications ,Opportunities into Regions,Trend and Growth … – Expert Consulting

Global Synthetic Biology Tools Market 2018|Types, Applications ,Opportunities into Regions,Trend and Growth …Expert ConsultingSynthetic Biology Tools market shows an Active growth during the forecast period 2018-2025. Synthetic Biology Tools market r… Continue reading

2018-05-25 Michael Zand NEWS

How Hematopoietic Stem Cells Balance Activation and Dormancy – Technology Networks

Technology NetworksHow Hematopoietic Stem Cells Balance Activation and DormancyTechnology NetworksHematopoietic Stem Cells (HSCs) give rise to blood and immune cells of the body, and are therefore essential for our survival. They are in a dormant state… Continue reading

2018-05-25 Michael Zand NEWS

Rounds Report: Crispr Rallied While The FDA Approved Lumivascular – Seeking Alpha

Post AnalystRounds Report: Crispr Rallied While The FDA Approved LumivascularSeeking AlphaThe bioscience market logged further gains for the second consecutive day this week. Many equities under our coverage continued to move northbound. Crispr Therape… Continue reading

2018-05-25 Michael Zand NEWS

Rounds Report: Crispr Rallied While The FDA Approved Lumivascular – Seeking Alpha

Post AnalystRounds Report: Crispr Rallied While The FDA Approved LumivascularSeeking AlphaThe bioscience market logged further gains for the second consecutive day this week. Many equities under our coverage continued to move northbound. Crispr Therape… Continue reading

2018-05-25 Michael Zand NEWS

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma – Surviving Mesothelioma

Continue reading

2018-05-25 Michael Zand NEWS

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma – Surviving Mesothelioma


Surviving Mesothelioma

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma
Surviving Mesothelioma
AstraZeneca’s immunotherapy drug tremelimumab may still have a chance as a novel mesothelioma treatment, even though an international clinical trial completed last year found that it did not extend mesothelioma survival. In a new study published in The …

Continue reading

2018-05-25 Michael Zand NEWS

Stem cell biotech Magenta Therapeutics files for a $100 million IPO – Nasdaq

NasdaqStem cell biotech Magenta Therapeutics files for a $100 million IPONasdaqMagenta Therapeutics, which is developing novel therapies to make stem cell transplants more effective, filed on Thursday with the SEC to raise up to $100 million in an init… Continue reading

2018-05-24 Michael Zand NEWS
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Surviving Mesothelioma

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma
Surviving Mesothelioma
AstraZeneca’s immunotherapy drug tremelimumab may still have a chance as a novel mesothelioma treatment, even though an international clinical trial completed last year found that it did not extend mesothelioma survival. In a new study published in The …